Blog

[:content [\9 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \T \h \e \space \G \e \r \m \a \n \space \F \e \d \e \r \a \l \space \J \o \i \n \t \space \C \o \m \m \i \t \t \e \e \space \( \G \- \B \A \) \, \space \t \h \e \space \d \e \c \i \s \i \o \n \- \m \a \k \i \n \g \space \b \o \d \y \space \o \f \space \t \h \e \space \s \e \l \f \- \g \o \v \e \r \n \i \n \g \space \h \e \a \l \t \h \c \a \r \e \space \s \y \s \t \e \m \space \i \n \  \G \e \r \m \a \n \y \, \space \r \e \c \e \n \t \l \y \space \c \o \n \f \i \r \m \e \d " ..."]]

[:content [\3 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \D \a \b \r \a \f \e \n \i \b \space \( \T \a \f \i \n \l \a \r \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \s \i \n \c \e \space \A \u \g \u \s \t \space \2 \0 \1 \3 \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \a \d \v \a \n \c \e \d \space \m \e \l \a \n \o \m \a \. \space \I \n \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \, " ..."]]

[:content [\I \Q \W \i \G \space \h \a \s \space \f \o \u \n \d \space \t \h \a \t \space \S \t \r \i \b \i \l \d \  \h \a \s \space \a \space \\ \" \s \m \a \l \l \e \r \\ \" \space \b \e \n \e \f \i \t \space \t \h \a \n \space \t \h \e \space \c \o \m \p \a \r \a \t \o \r \space \A \t \r \i \p \l \a \  \w \h \e \n \space \u \s \e \d \space \t \o \  \t \r \e \a \t \space \H \I \V \- \1 \space \i \n \f \e \c \t \i \o \n \space \i \n \space \t \r \e \a \t \m \e \n \t \- \n \a \Ã \¯ \v \e \space \a \d \u \l \t \s \space \o \r " ..."]]

Since November 2014 nintedanib (trade name: Vargatef) has been approved in combination with docetaxel for the treatment of adults with ...

Eribulin mesylate (Halaven) is approved for women with locally advanced or metastatic breast cancer in whom the disease has progressed ...

[:content [\1 \8 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \G \e \r \m \a \n \y \space \i \s \space \c \o \n \s \i \d \e \r \i \n \g \space \l \e \g \i \s \l \a \t \i \o \n \space \t \h \i \s \space \w \e \e \k \space \t \h \a \t \space \w \o \u \l \d \space \f \o \r \c \e \space \d \r \u \g \m \a \k \e \r \s \space \t \o \space \r \e \p \o \r \t \space \t \h \e \space \r \e \d \u \c \e \d \space \p \r \i \c \e \s \space \t \h \e \y \space \n \e \g \o \t \i \a \t \e " ..."]]

The drug dasabuvir (trade name Exviera) has been available since January 2015 for the treatment of adults with chronic hepatitis ...

The introduction of the first disease management programmes was the starting point for providing a legal basis for evidence-based medicine ...

Simoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A haemophilia, an inherited disorder ...

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive (“add-on”) therapy for adults and children ...

Pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and ...

[:content [\2 \space \M \a \y \space \2 \0 \1 \4 \space \- \space \S \o \f \o \s \b \u \v \i \r \space \h \a \s \space \b \e \e \n \space \a \v \a \i \l \a \b \l \e \space \s \i \n \c \e \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \p \a \t \i \e \n \t \s \space \w \i \t \h \  \c \h \r \o \n \i \c \  \h \e \p \a \t \i \t \i \s \  \C \  \i \n \f \e \c \t \i \o \n \. \  \T \h \e \space \I \n \s \t \i \t \u \t \e \space \f \o \r \space \Q \u \a \l \i \t \y " ..."]]

Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet ...

[:content [\A \space \w \e \e \k \space \a \f \t \e \r \space \G \e \r \m \a \n \y \' \s \space \F \e \d \e \r \a \l \space \J \o \i \n \t \space \C \o \m \m \i \t \t \e \e \space \( \G \- \B \A \) \space \i \s \s \u \e \d \space \i \t \s \space \f \i \n \a \l \space \b \e \n \e \f \i \t \space \a \s \s \e \s \s \m \e \n \t \space \o \f \space \D \P \P \- \4 \space \i \n \h \i \b \i \t \o \r \s \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f " ..."]]